Exchange Capital Management, Inc. Biogen Inc. Transaction History

Exchange Capital Management, Inc.

$598 Million
Q2 2024

A detailed history of Exchange Capital Management, Inc. transactions in Biogen Inc. stock. As of the latest transaction made, Exchange Capital Management, Inc. holds 20,139 shares of BIIB stock, worth $3.8 Million. This represents 0.78% of its overall portfolio holdings.

Number of Shares

20,139

Previous 20,348 1.03%

Holding current value

$3.8 Million

Previous $4.39 Million 6.41%

% of portfolio

0.78%

Previous 0.73%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 23, 2024	SELL	$190.52 - $236.72 $39,818 - $49,474	-209 Reduced 1.03%	20,139 $4.67 Million
Q1 2024 Apr 18, 2024	BUY	$212.02 - $267.71 $10,601 - $13,385	50 Added 0.25%	20,348 $4.39 Million
Q4 2023 Feb 08, 2024	BUY	$222.59 - $267.94 $204,782 - $246,504	920 Added 4.75%	20,298 $5.25 Million
Q3 2023 Oct 30, 2023	SELL	$253.3 - $285.89 $48,127 - $54,319	-190 Reduced 0.97%	19,378 $4.98 Million
Q2 2023 Jul 24, 2023	SELL	$275.25 - $318.06 $34,131 - $39,439	-124 Reduced 0.63%	19,568 $5.57 Million
Q1 2023 May 03, 2023	BUY	$256.56 - $292.34 $76,198 - $86,824	297 Added 1.53%	19,692 $5.47 Million
Q4 2022 Jan 31, 2023	SELL	$252.44 - $306.72 $202,456 - $245,989	-802 Reduced 3.97%	19,395 $5.37 Million
Q3 2022 Oct 31, 2022	SELL	$194.69 - $268.46 $54,513 - $75,168	-280 Reduced 1.37%	20,197 $5.39 Million
Q2 2022 Jul 28, 2022	BUY	$187.54 - $223.02 $23,630 - $28,100	126 Added 0.62%	20,477 $4.18 Million
Q1 2022 Apr 28, 2022	BUY	$193.77 - $244.14 $165,673 - $208,739	855 Added 4.39%	20,351 $4.29 Million
Q4 2021 Jan 27, 2022	BUY	$223.92 - $287.77 $143,980 - $185,036	643 Added 3.41%	19,496 $4.68 Million
Q3 2021 Nov 01, 2021	SELL	$282.99 - $369.05 $191,018 - $249,108	-675 Reduced 3.46%	18,853 $5.34 Million
Q2 2021 Aug 05, 2021	BUY	$259.0 - $414.71 $120,176 - $192,425	464 Added 2.43%	19,528 $6.76 Million
Q1 2021 May 10, 2021	BUY	$242.95 - $284.63 $192,173 - $225,142	791 Added 4.33%	19,064 $5.33 Million
Q4 2020 Feb 05, 2021	BUY	$236.26 - $355.63 $1.27 Million - $1.91 Million	5,375 Added 41.67%	18,273 $4.47 Million
Q3 2020 Nov 06, 2020	BUY	$264.77 - $305.71 $114,380 - $132,066	432 Added 3.47%	12,898 $3.66 Million
Q2 2020 Aug 04, 2020	SELL	$258.66 - $342.55 $34,401 - $45,559	-133 Reduced 1.06%	12,466 $3.34 Million
Q1 2020 Apr 28, 2020	BUY	$268.85 - $341.04 $427,202 - $541,912	1,589 Added 14.43%	12,599 $3.99 Million
Q4 2019 Jan 29, 2020	BUY	$220.06 - $304.07 $664,361 - $917,987	3,019 Added 37.78%	11,010 $3.27 Million
Q3 2019 Nov 07, 2019	BUY	$217.44 - $243.88 $1.74 Million - $1.95 Million	7,991 New	7,991 $1.86 Million

Others Institutions Holding BIIB

# of Institutions

1,049

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $27.2B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exchange Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Exchange Capital Management, Inc. with notifications on news.

Account

Exchange Capital Management, Inc. Biogen Inc. Transaction History